COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.
Parrotta E, Kister I, Charvet L, Sammarco C, Saha V, Charlson RE, Howard J, Gutman JM, Gottesman M, Abou-Fayssal N, Wolintz R, Keilson M, Fernandez-Carbonell C, Krupp LB, Zhovtis Ryerson L.
Parrotta E, et al. Among authors: fernandez carbonell c.
Neurol Neuroimmunol Neuroinflamm. 2020 Jul 9;7(5):e835. doi: 10.1212/NXI.0000000000000835. Print 2020 Sep.
Neurol Neuroimmunol Neuroinflamm. 2020.
PMID: 32646885
Free PMC article.